SJ Tepper

1.8k total citations
32 papers, 1.2k citations indexed

About

SJ Tepper is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, SJ Tepper has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Psychiatry and Mental health, 17 papers in Pathology and Forensic Medicine and 13 papers in Physiology. Recurrent topics in SJ Tepper's work include Migraine and Headache Studies (25 papers), Trigeminal Neuralgia and Treatments (13 papers) and Sympathectomy and Hyperhidrosis Treatments (11 papers). SJ Tepper is often cited by papers focused on Migraine and Headache Studies (25 papers), Trigeminal Neuralgia and Treatments (13 papers) and Sympathectomy and Hyperhidrosis Treatments (11 papers). SJ Tepper collaborates with scholars based in United States, United Kingdom and Italy. SJ Tepper's co-authors include ME Bigal, FD Sheftell, AM Rapoport, RB Lipton, Marcelo E. Bigal, Richard B. Lipton, J. G. Speciali, Alan M. Rapoport, Fred D. Sheftell and A. M. Rapoport and has published in prestigious journals such as Neurology, Headache The Journal of Head and Face Pain and Cephalalgia.

In The Last Decade

SJ Tepper

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SJ Tepper United States 18 1.0k 707 521 145 143 32 1.2k
Fabio Frediani Italy 21 1.1k 1.0× 644 0.9× 403 0.8× 103 0.7× 200 1.4× 78 1.3k
F. G. Freitag United States 8 1.0k 1.0× 574 0.8× 385 0.7× 101 0.7× 104 0.7× 9 1.1k
Christian Lampl Austria 20 1.3k 1.3× 743 1.1× 424 0.8× 144 1.0× 162 1.1× 42 1.5k
Gilles Géraud France 14 1.0k 1.0× 719 1.0× 476 0.9× 83 0.6× 102 0.7× 24 1.2k
Yuju Ma United States 10 1.4k 1.4× 1.0k 1.4× 614 1.2× 173 1.2× 116 0.8× 21 1.7k
Michael J. Marmura United States 20 1.3k 1.2× 755 1.1× 494 0.9× 147 1.0× 132 0.9× 59 1.5k
MB Russell Denmark 15 1.2k 1.1× 660 0.9× 431 0.8× 122 0.8× 92 0.6× 20 1.3k
Walter F. Stewart United States 5 1.2k 1.2× 738 1.0× 431 0.8× 154 1.1× 94 0.7× 6 1.4k
AM Rapoport United States 16 819 0.8× 547 0.8× 359 0.7× 115 0.8× 155 1.1× 23 985
H Massiou France 25 1.7k 1.6× 1.1k 1.5× 730 1.4× 190 1.3× 219 1.5× 55 2.0k

Countries citing papers authored by SJ Tepper

Since Specialization
Citations

This map shows the geographic impact of SJ Tepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SJ Tepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SJ Tepper more than expected).

Fields of papers citing papers by SJ Tepper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SJ Tepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SJ Tepper. The network helps show where SJ Tepper may publish in the future.

Co-authorship network of co-authors of SJ Tepper

This figure shows the co-authorship network connecting the top 25 collaborators of SJ Tepper. A scholar is included among the top collaborators of SJ Tepper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SJ Tepper. SJ Tepper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ashina, Messoud, SJ Tepper, Uwe Reuter, et al.. (2021). P.030 Long-term Safety and Tolerability of Atogepant 60 mg Following Once-Daily Dosing Over 1 Year for the Preventive Treatment of Migraine. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48(s3). S28–S29. 2 indexed citations
2.
Sapra, Sandhya, et al.. (2016). Development of a Responder Definition for the Migraine Physical Function Impact Diary (MPFID). Value in Health. 19(7). A383–A383. 1 indexed citations
3.
Tepper, SJ, Shashidhar Kori, Peter J. Goadsby, et al.. (2011). Migraine Recurrence Rates : A Case for Standardizing the Definition. Headache The Journal of Head and Face Pain. 51. 17–17. 2 indexed citations
4.
Tepper, SJ, Fred D. Sheftell, & Marcelo E. Bigal. (2007). The patent foramen ovale–migraine question. Neurological Sciences. 28(S2). S118–S123. 20 indexed citations
5.
Sheftell, Fred D., SJ Tepper, Christine Lay, & Marcelo E. Bigal. (2007). Post-traumatic headache: emphasis on chronic types following mild closed head injury. Neurological Sciences. 28(S2). S203–S207. 17 indexed citations
6.
Rapoport, Alan M., SJ Tepper, Fred D. Sheftell, Ethan Kung, & Marcelo E. Bigal. (2006). Which triptan for which patient?. Neurological Sciences. 27(S2). s123–s129. 22 indexed citations
7.
Bigal, ME, SJ Tepper, FD Sheftell, AM Rapoport, & RB Lipton. (2006). Field Testing Alternative Criteria for Chronic Migraine. Cephalalgia. 26(4). 477–482. 48 indexed citations
8.
Rapoport, AM, et al.. (2006). Persistent Idiopathic Facial Pain Responsive to Topiramate. Cephalalgia. 26(4). 489–491. 9 indexed citations
9.
Dowson, Andrew, SJ Tepper, & C Dahlöf. (2005). Patients’ preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine. The Journal of Headache and Pain. 6(3). 112–120. 17 indexed citations
10.
Bigal, ME, Alan M. Rapoport, FD Sheftell, SJ Tepper, & Richard B. Lipton. (2005). Chronic migraine is an earlier stage of transformed migraine in adults. Neurology. 65(10). 1556–1561. 41 indexed citations
11.
Sheftell, FD, SJ Tepper, & ME Bigal. (2005). Migraine: barriers for care. Neurological Sciences. 26(S2). s140–s142. 8 indexed citations
12.
Tepper, SJ, et al.. (2005). Short-Lasting Unilateral Neuralgiform Headache Attacks with Cranial Autonomic Symptoms (SUNA)—-A Case Report. Cephalalgia. 25(6). 470–472. 19 indexed citations
13.
Bigal, ME, SJ Tepper, Michele Feleppa, et al.. (2005). Headache Prevention Outcome and Body Mass Index. Cephalalgia. 26(4). 445–450. 39 indexed citations
14.
Tepper, SJ, et al.. (2005). Botulinum Toxin A for the Treatment of Greater Occipital Neuralgia and Trigeminal Neuralgia. Cephalalgia. 26(3). 336–340. 27 indexed citations
15.
Dowson, Andrew, et al.. (2004). Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire. Current Medical Research and Opinion. 20(7). 1125–1135. 51 indexed citations
16.
Ramadan, NM, SD Silberstein, KW Johnson, et al.. (2004). LY293558, a Novel AMPA/GluR5 Antagonist, is Efficacious and Well-Tolerated in Acute Migraine. Cephalalgia. 24(7). 596–602. 138 indexed citations
17.
Tepper, SJ, FD Sheftell, & Alan M. Rapoport. (2000). Evidence-Based Guidelines for Migraine Headache. Journal watch. 2000. 8 indexed citations
18.
Tepper, SJ. (1998). Sumatriptan nasal spray. Cephalalgia. 18(5). 242–242. 1 indexed citations
19.
Tepper, SJ, et al.. (1998). SUMATRIPTAN SUPPOSITORIES FOR THE ACUTE TREATMENT OF MIGRAINE. International Journal of Clinical Practice. 52(1). 31–35. 16 indexed citations
20.
Tepper, SJ, et al.. (1993). Invasive Haemophilus Influenzae Type B Disease. Journal of Forensic Sciences. 38(1). 94–97. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026